SNDX 8-K 2026-01-12

Syndax Pharmaceuticals Inc (SNDX) 8-K dated 2026-01-12 — accession 0001193125-26-010486. This URL is the filing, not the SNDX hub.

Syndax Pharmaceuticals Inc (SNDX) is a biotechnology company listed on US.

Syndax Pharmaceuticals Inc filed a 8-K on 2026-01-12. Accession 0001193125-26-010486.

Cached items: 2.02, 7.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported SNDX revenue for 2026-06-30 was $137.7M. Net income was -$92.0M. SNDX currently screens at market cap $774.4M.

Not investment advice. The SNDX SEC hub lists recent forms. The stock page is the research view.